Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • Oct 7, 2017
    New Jersey Sues Insys Over Subsys Marketing
  • Oct 7, 2017
    Newark Joins Cities Suing Opioid Makers
  • Oct 7, 2017
    Insys Therapeutics Settles with Massachusetts Over Fentanyl Marketing
  • Oct 6, 2017
    Court Dismisses FTC-New York Case Over Claims Made by Dietary Supplement Maker
  • Oct 5, 2017
    OPDP Study Finds Little Physician Understanding of Clinical Trial Terms
  • Oct 1, 2017
    Washington and Seattle File Separate Suits Against Purdue Pharma over Marketing
  • Sep 29, 2017
    NAD Refers FemaLife Advertising Concerns To FTC After Company Refuses NAD Process
  • Sep 26, 2017
    Canadian Study Finds Most Heavily Promoted Drugs Have Little Therapeutic Gain
  • Sep 25, 2017
    Aegerion Settles Charges over Juxtapid Marketing; Will Have CIA, Consent Decree
  • Sep 22, 2017
    Five Companies Cited in Journal Ads for Breaching ABPI Code of Ethics
  • More

Good Clinical Practice

  • Feb 2, 2018
    Use of Biomarkers in Trials Aids Product Approval Rates
  • Jan 31, 2018
    FDA To Have Public Meeting on Trial Inclusion and Exclusion Criteria April 16
  • Jan 31, 2018
    ACRP Releases CRC Competency Guidelines
  • Jan 30, 2018
    FDA Clarifies Guidance on Subject Payment
  • Jan 27, 2018
    District Court Finds Clinical Trials Conducted in a State Do Not Provide Personal Jurisdiction
  • Jan 26, 2018
    FDA Issues Draft Guidance on Testing Fixed-dose Combination Drugs for Hypertension
  • Jan 25, 2018
    ‘Right-to-Try’ Bill Carried Over to New Session of Nebraska Legislature
  • Jan 25, 2018
    NIH Extends Trial Inclusion Policy to All Ages
  • Jan 24, 2018
    Shire Requires Open Access Publication
  • Jan 24, 2018
    Calif. Appeals Court Reverses Judgment Against Trial Sponsor Over Clinical Trial Subject’s Death
  • More

U.S. Food Labeling

  • Jul 31,2012
    Product Recalls
  • Jun 30,2012
    Mandatory Labeling of Genetically Engineered Foods Gets Certified for Ballot in California
  • Jun 30,2012
    Get Your Newsletter Faster Online!
  • Jun 30,2012
    Court Rejects FTC Effort To Require Two Studies
  • Jun 30,2012
    FDA Denies Corn Refiners' Petition for 'Corn Sugar' As Alternate Name for High Fructose Corn Syrup
  • Jun 30,2012
    Frito-Lay Adds 'Gluten-Free' Icon on Packaging of Qualifying Products in Snack Food Line
  • Jun 30,2012
    Chobani Sued over 'Evaporated Cane Juice'
  • Jun 30,2012
    NAD Tells Ocean Spray To Stop Running Sodium Claims Against V8 Vegetable Juice
  • Jun 30,2012
    Product Recalls
  • May 31,2012
    WTO Appellate Panel Rules Against U.S. in 'Dolphin Safe' Tuna Labeling Case
  • More

FDA Regulation & Enforcement

  • Sep 29, 2020
    Abrams Retires from OPDP
  • Sep 29, 2020
    ​​​​​​​AMS Announces Decision on OLPP Rule
  • Sep 29, 2020
    NOSB Will Hold Online Meeting in Late October
  • Sep 23, 2020
    Herbalife To Pay Over $122 Million To Settle Allegations of Foreign Corrupt Practices Violations in China
  • Sep 23, 2020
    Proposed Rule Outlines Evidence Relevant to FDA’s Determination of Intended Uses of Medical Devices
  • Sep 23, 2020
    FDA Extends Facts Panel Compliance Flexibility to Small Firms
  • Sep 20, 2020
    OPDP Researchers To Examine Medical Conference Attendees’ Observations on Drug Promotion
  • Sep 17, 2020
    Court Issues First Consent Decree of Permanent Injunction Stemming from FSMA Produce Safety Rule Violations
  • Sep 17, 2020
    FSIS Proposes To Expand Categories of Products Eligible for Generic Label Approval
  • Sep 16, 2020
    OPDP Issues Warning Letter Over Radio Ad
  • More

Medical Devices

  • Apr 7, 2015
    FDA Submits Plans for Practitioner Survey on Standardized Content, Format for Device Labeling to OMB
  • Apr 6, 2015
    Medtronic Settles Allegations That It Illegally Sold Devices Made Overseas to the Government
  • Apr 2, 2015
    Draft Guidance Details Possible Topics, Procedures for FDA Devices Advisory Committee Meetings
  • Mar 26, 2015
    FDA, Device Industry Working To Harmonize Their Responses to Postmarket Problems
  • Mar 16, 2015
    Guidance on Reprocessing Reusable Devices Stresses Validation Methods, Labeling
  • Mar 12, 2015
    FDA Case Study Outlines De Novo Procedure
  • Mar 4, 2015
    Proposed Legislation Would Protect FDA User Fees From Sequestration
  • Mar 4, 2015
    Report: Public-Private Partnership Should Develop, Manage Data-Driven Device Surveillance System
  • Feb 26, 2015
    FDA Public Workshop To Focus on Robotically Assisted Surgical Devices
  • Feb 19, 2015
    Final Guidance From CDRH Addresses Problems With Small-Bore Connectors for Enteral Devices
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.